Thus, the analysis of previous studies indicated that the DAP was effective in retarding the progression of RA and other inflammatory diseases even at low doses via inhibiting the pro-inflammatory cytokines, NF-κB and MMP levels, and restored the protein expressions. This evidence concerns the gene NFKB1 and rheumatoid arthritis.